Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003678 |
---|---|
Receipt number | R000004460 |
Scientific Title | An Open label multi- facilities cooperation randomized control trial to verify renoprotective effects of Aliskiren treatment in the chronic kidney disease (CKD). |
Date of disclosure of the study information | 2010/07/01 |
Last modified on | 2022/04/06 10:25:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/31 09:59:06 | ||
2 | Update | 2010/05/31 15:52:20 | Target sample size |
|
3 | Update | 2010/06/04 09:50:20 | Date of protocol fixation Anticipated trial start date |
|
4 | Update | 2010/06/04 09:51:22 | Date of protocol fixation Anticipated trial start date |
|
5 | Update | 2010/07/13 15:56:21 | Target sample size |
|
6 | Update | 2010/08/23 14:27:31 | Email |
|
7 | Update | 2011/06/07 10:48:08 | Public title |
|
8 | Update | 2011/06/30 09:06:43 | Anticipated trial start date |
|
9 | Update | 2012/01/04 09:23:52 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2015/06/08 10:14:48 | Recruitment status |
|
11 | Update | 2022/04/06 10:25:27 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Address Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Email1 Organization Organization Address Address Tel |